August 27, 2026 | Intelligent Commercialization, Pharma, healthcare
Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.

In our latest series of articles, our experts explore how Intelligent Commercialization™ is helping pharma teams turn insights into action across the lifecycle.
This content was provided by Inizio
Latest Content from Inizio
As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.
Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.
What does the future hold for the US pharma industry?
Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.
Pharma companies are increasingly looking for ways to provide “beyond the pill” services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment…
Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.
One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.
Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.
Understanding the opportunities for biosimilars and the threats to innovator biologics
The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers…
